Skip to content
Lower risk Medical device recall · FDA · Published May 27, 2024

Beckman Coulter IGM 4x14 mL R1 R2: Incorrect Lipemia Settings May Cause False Results

Beckman Coulter recalls specific IGM 4x14 mL R1 and 4x11 mL R2 test kits due to incorrect lipemia settings that may cause patient samples to show false low results or normal results for high results.

🇺🇸 FDA recall #Z-2428-2024Medical deviceBeckman Coulter ›
Take action

Contact the company

Recalling firmBeckman Coulter Inc.250 S Kraemer Blvd · Brea, CA 92821-6232
✎ GovInfoNow plain-language explainer

Beckman Coulter is recalling certain IGM 4x14 mL R1 and 4x11 mL R2 test kits because their lipemia settings might cause patient samples to be reported as false low results or cause high results to appear normal. This could lead to incorrect medical diagnoses if the test is used without correction. Read more at govinfonow.com/recall/55020-beckman-coulter-igm-4x14-ml-r1-r2-incorrect-lipemia-settings.

Source Summary by GovInfoNow · govinfonow.com/recall/55020-beckman-coulter-igm-4x14-ml-r1-r2-incorrect-lipemia-settings · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2428-2024

Cite this page

“Beckman Coulter IGM 4x14 mL R1 R2: Incorrect Lipemia Settings May Cause False Results.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/55020-beckman-coulter-igm-4x14-ml-r1-r2-incorrect-lipemia-settings. Based on FDA recall #Z-2428-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2428-2024%22&limit=1).

The FDA announced on May 27, 2024, that Beckman Coulter Inc. is recalling its IGM reagents due to incorrect LIH Influence check settings for Lipemia. This error may cause patient samples to be reported with false low results or high results to report as normal.

How to tell if you have it

  • Brand: Beckman Coulter
  • Product: REF: OSR61173, IGM 4x14 mL R1, 4x11 mL R2
  • UDI: 15099590011598
  • Lots: 2548, 2549, 2550, 2551, 2552, 2553, 2554
  • Expirations: 2024-06-01, 2024-10-01, 2024-11-01, 2025-04-01, 2025-07-01, 2025-10-01, 2026-03-01
  • Units affected: 13,565

The hazard

According to the FDA, the LIH Influence check settings for Lipemia are incorrect. This defect may result in patient samples being reported as false low results or cause a high result to report as normal.

Context

GovInfoNow's records show Beckman Coulter, Inc. has had 132 other recalls on record since June 20, 2017. Other recent recalls of similar products include Beckman Coulter DxC 500i Modules with Software 1.5 Risk: Erroneous Test Results (July 15, 2026), Beckman Coulter MicroScan LabPro V5.03 Panel Update 11 DVD Kit: Incorrect Algorithms May Affect Test Results (June 26, 2026), and Beckman Coulter Access Total T4 Calibrator Recall: False Low Results Risk Incorrect Treatment (March 16, 2026).

How to tell if you have this one

Check the unique device identifier (UDI) on the kit, which starts with 15099590011598. Also look for the lot numbers 2548 through 2554, which expire between June 2024 and October 2025.

  • Brand
    Beckman Coulter
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Details

    Verify the unique device identifier (UDI) starts with 15099590011598 and the lot number is between 2548 and 2554.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 41 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: nationwideMAOregon: named in the noticeORNevada: nationwideNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: nationwideVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MD, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, WA, WI, WV, WY…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: May 27, 202412. FDA classified it Class II: Jul 24, 202423. Published in FDA’s Enforcement Report: Jul 31, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2428-2024 (May 27, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2428-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA